Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

United Therapeutic (UTHR)

United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
United Therapeutics Corporation to Present at the Leerink Global Healthcare Conference Business Wire - Tue Mar 3, 6:00AM CST

United Therapeutics Corporation (Nasdaq: UTHR ) announced today that Dr. Martine Rothblatt , Chairperson and Chief Executive Officer, will...

UTHR : 478.16 (-1.42%)
United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy Business Wire - Mon Mar 2, 5:30AM CST

The phase 3 ADVANCE OUTCOMES study of ralinepag met its primary endpoint and several important secondary endpoints, including increasing odds of clinical improvement by 47%, in predominantly pre-treated...

UTHR : 478.16 (-1.42%)
Zoetis Inc logo on phone-by viewimage via Shutterstock
Zoetis Stock: Is ZTS Underperforming the Healthcare Sector? Barchart - Fri Feb 27, 4:29AM CST

Zoetis has underperformed the healthcare sector over the past year, and analysts remain moderately optimistic about the stock’s outlook.

XLV : 152.70 (-0.79%)
ZTS : 121.43 (-0.65%)
UTHR : 478.16 (-1.42%)
SFM
2 Cash-Producing Stocks to Keep an Eye On and 1 That Underwhelm StockStory - Thu Feb 26, 10:46PM CST

2 Cash-Producing Stocks to Keep an Eye On and 1 That Underwhelm

SFM : 80.25 (+4.34%)
COTY : 2.37 (-1.25%)
UTHR : 478.16 (-1.42%)
UTHR
Why United Therapeutics (UTHR) Shares Are Sliding Today StockStory - Thu Feb 26, 11:25AM CST

Why United Therapeutics (UTHR) Shares Are Sliding Today

UTHR : 478.16 (-1.42%)
UTHR
United Therapeutics (NASDAQ:UTHR) Misses Q4 CY2025 Revenue Estimates StockStory - Wed Feb 25, 5:47AM CST

United Therapeutics (NASDAQ:UTHR) Misses Q4 CY2025 Revenue Estimates

UTHR : 478.16 (-1.42%)
United Therapeutics: Q4 Earnings Snapshot AP - Wed Feb 25, 5:45AM CST

United Therapeutics: Q4 Earnings Snapshot

UTHR : 478.16 (-1.42%)
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results Business Wire - Wed Feb 25, 5:30AM CST

United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, today announced its financial results for the quarter and year ended December 31, 2025. Full year 2025 revenues...

UTHR : 478.16 (-1.42%)
UTHR
United Therapeutics (UTHR) Q4 Earnings Report Preview: What To Look For StockStory - Mon Feb 23, 9:22PM CST

United Therapeutics (UTHR) Q4 Earnings Report Preview: What To Look For

UTHR : 478.16 (-1.42%)
United Therapeutics Corporation to Present at the TD Cowen 46th Annual Health Care Conference Business Wire - Mon Feb 23, 6:00AM CST

United Therapeutics Corporation (Nasdaq: UTHR ) announced today that Michael Benkowitz , President and Chief Operating Officer, will provide a company overview...

UTHR : 478.16 (-1.42%)

Barchart Exclusives

Iran War, CPI and Other Key Thing to Watch this Week Barchart - Sun Mar 8, 12:00PM CDT
Markets enter a critical week following last week's February jobs report that showed the U.S. economy lost around 92,000 jobs, which was a dramatic miss that has intensified recession concerns and raised questions about economic resilience amid escalating geopolitical tensions. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot